| The relationship of lymphocyte recovery and prognosis of esophageal cancer patients with severe radiation-induced lymphopenia after chemoradiation therapy W Deng, C Xu, A Liu, PSN van Rossum, W Deng, Z Liao, AC Koong, ... Radiotherapy and Oncology 133, 9-15, 2019 | 58 | 2019 |
| Prediction of severe lymphopenia during chemoradiation therapy for esophageal cancer: development and validation of a pretreatment nomogram PSN van Rossum, W Deng, DM Routman, AY Liu, C Xu, Y Shiraishi, ... Practical radiation oncology 10 (1), e16-e26, 2020 | 56 | 2020 |
| Integrating an open source Monte Carlo code “MCsquare” for clinical use in intensity‐modulated proton therapy W Deng, JE Younkin, K Souris, S Huang, K Augustine, M Fatyga, X Ding, ... Medical physics 47 (6), 2558-2574, 2020 | 49 | 2020 |
| Small‐spot intensity‐modulated proton therapy and volumetric‐modulated arc therapies for patients with locally advanced non‐small‐cell lung cancer: a dosimetric comparative study C Liu, TT Sio, W Deng, J Shan, TB Daniels, WG Rule, PR Lara, SM Korte, ... Journal of applied clinical medical physics 19 (6), 140-148, 2018 | 49 | 2018 |
| A critical review of LET-based intensity-modulated proton therapy plan evaluation and optimization for head and neck cancer management W Deng, Y Yang, C Liu, M Bues, R Mohan, WW Wong, RH Foote, ... International Journal of Particle Therapy 8 (1), 36-49, 2021 | 46 | 2021 |
| Nomogram to predict overall survival for thoracic esophageal squamous cell carcinoma patients after radical esophagectomy W Deng, W Zhang, J Yang, W Ni, S Yu, C Li, X Chang, Z Zhou, D Chen, ... Annals of Surgical Oncology 26, 2890-2898, 2019 | 39 | 2019 |
| Advances in radiotherapy for esophageal cancer W Deng, SH Lin Annals of translational medicine 6 (4), 2018 | 38 | 2018 |
| NTCP model for postoperative complications and one-year mortality after trimodality treatment in oesophageal cancer M Thomas, G Defraene, M Lambrecht, W Deng, J Moons, P Nafteux, ... Radiotherapy and Oncology 141, 33-40, 2019 | 34 | 2019 |
| Postoperative radiotherapy in pathological T2–3N0M0 thoracic esophageal squamous cell carcinoma: interim report of a prospective, phase III, randomized controlled study W Deng, J Yang, W Ni, C Li, X Chang, W Han, Z Zhou, D Chen, Q Feng, ... The Oncologist 25 (4), e701-e708, 2020 | 32 | 2020 |
| Patterns of recurrence after surgery and efficacy of salvage therapy after recurrence in patients with thoracic esophageal squamous cell carcinoma W Ni, J Yang, W Deng, Z Xiao, Z Zhou, H Zhang, D Chen, Q Feng, J Liang, ... Bmc Cancer 20, 1-9, 2020 | 31 | 2020 |
| Hybrid 3D analytical linear energy transfer calculation algorithm based on precalculated data from Monte Carlo simulations W Deng, X Ding, JE Younkin, J Shen, M Bues, SE Schild, SH Patel, W Liu Medical physics 47 (2), 745-752, 2020 | 31 | 2020 |
| A phase I/II radiation dose escalation trial using simultaneous integrated boost technique with elective nodal irradiation and concurrent chemotherapy for unresectable … C Li, W Ni, X Wang, Z Zhou, W Deng, X Chang, D Chen, Q Feng, J Liang, ... Radiation oncology 14, 1-8, 2019 | 28 | 2019 |
| Clinical practice and outcome of radiotherapy for advanced esophageal squamous cell carcinoma between 2002 and 2018 in China: the multi-center 3JECROG Survey C Li, X Wang, L Wang, J Chen, W Zhang, Q Pang, Y Zhao, X Sun, ... Acta Oncologica 60 (5), 627-634, 2021 | 20 | 2021 |
| Interobserver variability in target volume delineation in definitive radiotherapy for thoracic esophageal cancer: a multi-center study from China X Chang, W Deng, X Wang, Z Zhou, J Yang, W Guo, M Liu, X Qi, L Li, ... Radiation Oncology 16 (1), 102, 2021 | 16 | 2021 |
| Radiation dose and pathological response in oesophageal cancer patients treated with neoadjuvant chemoradiotherapy followed by surgery: a multi-institutional analysis M Thomas, AS Borggreve, PSN van Rossum, C Perneel, J Moons, ... Acta Oncologica 58 (10), 1358-1365, 2019 | 15 | 2019 |
| A multicenter prospective phase III clinical randomized study of simultaneous integrated boost intensity-modulated radiotherapy with or without concurrent chemotherapy in … L Gao, X Wang, W Han, W Deng, C Li, X Wang, Y Zhao, W Ni, X Chang, ... BMC cancer 20, 1-10, 2020 | 13 | 2020 |
| A prognostic nomogram for overall survival after neoadjuvant radiotherapy or chemoradiotherapy in thoracic esophageal squamous cell carcinoma: a retrospective analysis W Deng, Q Wang, Z Xiao, L Tan, Z Yang, Z Zhou, H Zhang, D Chen, ... Oncotarget 8 (25), 41102, 2017 | 13 | 2017 |
| S-1–Based Chemoradiotherapy Followed by Consolidation Chemotherapy With S-1 in Elderly Patients With Esophageal Squamous Cell Carcinoma: A Multicenter Phase II Trial X Wang, X Ge, X Wang, W Zhang, H Zhou, Y Lin, S Qie, M Hu, W Wang, ... Frontiers in Oncology 10, 1499, 2020 | 12 | 2020 |
| Trends in conditional overall survival of esophageal cancer: a population-based study W Deng, R Yu, Z Yang, X Dong, W Wang Annals of translational medicine 9 (2), 2021 | 9 | 2021 |
| Comprehensive evaluation and implementation of two independent methods for beam monitor calibration for proton scanning beam J Shen, X Ding, Y Hu, Y Kang, W Liu, W Deng, M Bues Medical physics 46 (12), 5867-5875, 2019 | 7 | 2019 |
